June 3rd, 2023

By Elizabeth Goldstein-Rice

Prepare. Communicate. Find Support.

Read our Comprehensive Guide for the Newly Diagnosed

There are numerous and important reasons why someone who has been diagnosed with sarcoma should be treated at a center where…

May 20th, 2023

ANN ARBOR, MI May 9, 2023 – SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce that it has launched a national, virtual multidisciplinary sarcoma tumor board.

As the care of patients with cancer, particularly uncommon…

May 19th, 2023

Podcast: From Physician to Patient
Dan Hurley, M.D.

Dan Hurley, M.D. is an otolaryngologist (Ear, Nose, Throat) residing in Arizona. He was diagnosed with dediffereniated chondrosarcoma, a rare form of bone cancer. While he was preparing to receive…

May 15th, 2023

This coming Monday, May 22, we are going to do our first analysis of responses to the survey and take a first look at identifying trends and cause-effect relationships. Your responses to the survey questions are vital to this effort. We want to…

May 12th, 2023

During the past three years many CS Patients, caregivers, family members and friends have supported the Foundation through their donations and fund-raising activities. We received donations from family members in honor of their lost loved ones to…

May 11th, 2023

BOWIE, Maryland, May 12—The Chondrosarcoma (CS) Foundation will commemorate its third anniversary by continuing to educate the public about this rare bone cancer, advocate for patients fighting the disease and conduct a global natural history…

April 28th, 2023

The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, 2023. The Chondrosarcoma Patient Registry is a platform for patients around the world to strengthen their voices and collectively share…

April 22nd, 2023

Journal of Clinical Pathology

J Clin Pathol. 2018 Jul; 71(7): 579–583.
Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071

PMCID: PMC6204964
PMID: 29593061

Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong…

April 11th, 2023

The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx:

We have just released…

April 7th, 2023

The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to…